Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cedazuridine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Inqovi

    02 1Inqovi/Inaqovi

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Inqovi

    Cedazuridine

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : Inqovi

    Japan
    arrow
    The Pharmacy Technology
    Not Confirmed

    Otsuka

    Cedazuridine

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 54

    2020 Revenue in Millions : 12

    Growth (%) : 392

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Inqovi

    Cedazuridine

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : Inqovi

    Japan
    arrow
    The Pharmacy Technology
    Not Confirmed

    Otsuka

    Cedazuridine

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 80

    2021 Revenue in Millions : 54

    Growth (%) : 48

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Inqovi/Inaqovi

    Cedazuridine

    arrow
    The Pharmacy Technology
    Not Confirmed

    Brand Name : Inqovi/Inaqovi

    Japan
    arrow
    The Pharmacy Technology
    Not Confirmed

    Otsuka

    Cedazuridine

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 82

    2022 Revenue in Millions : 80

    Growth (%) : 16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF